celecoxib has been researched along with Esophageal Squamous Cell Carcinoma in 2 studies
Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We examined the effects of celecoxib, a COX-2 inhibitor, in enhancing the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma (ESCC) by reducing the COX-2 activity." | 3.80 | A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma. ( Akanuma, N; Akutsu, Y; Hanari, N; Hoshino, I; Hu, X; Isozaki, Y; Komatsu-Akimoto, A; Matsubara, H; Mori, M; Mutallip, M; Qin, W; Yusup, G, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noronha, V | 1 |
| Patil, VM | 1 |
| Menon, NS | 1 |
| Joshi, A | 1 |
| Goud, S | 1 |
| More, S | 1 |
| Kannan, S | 1 |
| Pawar, A | 1 |
| Nakti, D | 1 |
| Yadav, A | 1 |
| Shah, S | 1 |
| Mahajan, A | 1 |
| Janu, A | 1 |
| Kumar, R | 1 |
| Tibdewal, A | 1 |
| Mummudi, N | 1 |
| Agarwal, JP | 1 |
| Banavali, SD | 1 |
| Prabhash, K | 1 |
| Yusup, G | 1 |
| Akutsu, Y | 1 |
| Mutallip, M | 1 |
| Qin, W | 1 |
| Hu, X | 1 |
| Komatsu-Akimoto, A | 1 |
| Hoshino, I | 1 |
| Hanari, N | 1 |
| Mori, M | 1 |
| Akanuma, N | 1 |
| Isozaki, Y | 1 |
| Matsubara, H | 1 |
1 trial available for celecoxib and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Celecoxib; Chemoradiotherapy; Esophagea | 2022 |
1 other study available for celecoxib and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; C | 2014 |